
DECAF trial: continuing coffee cut AF recurrence after cardioversion, 47% vs 64%
A shared summary of the DECAF randomized trial in 200 habitual coffee drinkers with persistent atrial fibrillation or flutter after cardioversion. Those who kept drinking caffeinated coffee had fewer recurrences over 6 months than those who abstained, with no safety concerns, though the result does not justify starting coffee.



